HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Steve Lianoglou Selected Research
Steve Lianoglou Research Topics
Disease
7
Neoplasms (Cancer)
01/2020 - 01/2016
1
Alzheimer Disease (Alzheimer's Disease)
11/2022
1
Neuroinflammatory Diseases
01/2020
1
Central Nervous System Diseases (CNS Diseases)
01/2020
1
Demyelinating Diseases (Demyelinating Disease)
01/2020
1
Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2020
1
Mucopolysaccharidosis II (Hunter Syndrome)
01/2020
1
Glioblastoma (Glioblastoma Multiforme)
11/2019
1
Inflammation (Inflammations)
11/2019
1
Urinary Bladder Neoplasms (Bladder Cancer)
12/2018
1
Atrophy
01/2018
1
Pathologic Processes
11/2008
Drug/Important Bio-Agent (IBA)
3
Ligands
IBA
01/2020 - 01/2017
2
atezolizumab
IBA
12/2018 - 01/2018
1
Immunoglobulins (Immunoglobulin)
IBA
01/2020
1
Enzymes
IBA
01/2020
1
Iduronic Acid (Iduronate)
IBA
01/2020
1
Lipids
IBA
01/2020
1
Proteins (Proteins, Gene)
FDA Link
01/2020
1
RNA (Ribonucleic Acid)
IBA
01/2020
1
Peptides (Polypeptides)
IBA
11/2019
1
DNA Transposable Elements (Element, IS)
IBA
11/2019
1
Histocompatibility Antigens Class I
IBA
11/2019
1
TES
IBA
11/2019
1
Aminopeptidases
IBA
12/2018
1
Deubiquitinating Enzymes
IBA
01/2018
1
Collagen
IBA
01/2018
1
Tamoxifen
FDA Link
Generic
01/2018
1
Antibodies
IBA
01/2018
1
Programmed Cell Death 1 Receptor
IBA
01/2017
1
Pharmaceutical Preparations
IBA
01/2016
1
Oxygen (Dioxygen)
IBA
11/2008
Therapy/Procedure
3
Therapeutics
11/2022 - 12/2018
2
Immunotherapy
11/2019 - 12/2018
1
Enzyme Therapy
01/2020